Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Diabetes, obesity & metabolism"
topic_facet:"9100L32L2N"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%229100L32L2N%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%229100L32L2N%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%229100L32L2N%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (65)
1
Prusogliptin (DBPR108) monotherapy in treatment-naïve patients with type 2 diabetes : A randomized, double-blind, active and placebo-controlled, phase 3 study
enthalten in:
Diabetes, obesity & metabolism
| 2024
von
Wang, W.
|
Guo, X.
|
Zhang, C.
| +11
Wird geladen...
2
A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy
enthalten in:
Diabetes, obesity & metabolism
| 2023
von
Ji, L.
|
Lu, J.
|
Gao, L.
| +12
Wird geladen...
3
Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone : A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2023
von
Gao, L.
|
Cheng, Z.
|
Su, B.
| +15
Wird geladen...
4
Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes : A 24-week, multi-centre, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Xu, J.
|
Ling, H.
|
Geng, J.
| +8
Wird geladen...
5
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11) : A randomized, open-label, multinational, phase 3b trial
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Kellerer, M.
|
Kaltoft, M.
|
Lawson, J.
| +4
Wird geladen...
6
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes : Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Frías, J.
|
Maaske, J.
|
Suchower, L.
| +4
Wird geladen...
7
Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin : A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Weng, J.
|
Zeng, L.
|
Zhang, Y.
| +14
Wird geladen...
8
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China : A 30-week, double-blind, phase 3a, randomized trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Ji, L.
|
Dong, X.
|
Li, Y.
| +8
Wird geladen...
9
Efficacy and safety of polyethylene glycol loxenatide as add-on to metformin in patients with type 2 diabetes : A multicentre, randomized, double-blind, placebo-controlled, phase 3b trial
enthalten in:
Diabetes, obesity & metabolism
| 2020
von
Gao, F.
|
Lv, X.
|
Mo, Z.
| +8
Wird geladen...
10
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes : A randomized, parallel-design, open-label, Phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2020
von
Vilsbøll, T.
|
Ekholm, E.
|
Johnsson, E.
| +4
Wird geladen...
1
2
3
4
5
6
7
Nächster »
[7]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Diabetes, obesity & metabolism
Filter aufheben
Thema: 9100L32L2N
Medienart
65
Aufsätze
65
E-Artikel
65
E-Ressourcen
Zeitschriftentitel
Diabetes, obesity & metabolism
Thema
9100L32L2N
65
Clinical Trial, Phase III
65
Metformin
65
Randomized Controlled Trial
63
Journal Article
59
Hypoglycemic Agents
57
Research Support, Non-U.S. Gov't
53
Glycated Hemoglobin A
50
Multicenter Study
44
Blood Glucose
43
type 2 diabetes
32
hemoglobin A1c protein, human
20
metformin
18
Glucosides
15
Sulfonylurea Compounds
14
Benzhydryl Compounds
13
Dipeptidyl-Peptidase IV Inhibitors
13
SGLT2 inhibitor
12
Comparative Study
12
Sitagliptin Phosphate
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
55
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
65
Englisch
Haven't found what you're looking for?
Wird geladen...